Excelsior Medical Co., Ltd. (4104.TW)
TWD 84.9
(6.26%)
TWD 84.9
(6.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.24 Billion TWD | 7.44% |
| 2022 | 1.16 Billion TWD | 27.56% |
| 2021 | 910.24 Million TWD | 6.93% |
| 2020 | 851.23 Million TWD | -0.23% |
| 2019 | 853.18 Million TWD | -15.38% |
| 2018 | 1 Billion TWD | -10.13% |
| 2017 | 1.12 Billion TWD | 9.44% |
| 2016 | 1.02 Billion TWD | -8.08% |
| 2015 | 1.11 Billion TWD | -9.19% |
| 2014 | 1.22 Billion TWD | -4.33% |
| 2013 | 1.28 Billion TWD | 9.97% |
| 2012 | 1.16 Billion TWD | -8.61% |
| 2011 | 1.27 Billion TWD | -25.28% |
| 2010 | 1.7 Billion TWD | 15.65% |
| 2009 | 1.47 Billion TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.33 Billion TWD | 7.35% |
| 2024 Q2 | 1.14 Billion TWD | -14.35% |
| 2023 Q4 | 1.24 Billion TWD | -2.16% |
| 2023 FY | 1.24 Billion TWD | 7.44% |
| 2023 Q1 | 1.12 Billion TWD | -3.33% |
| 2023 Q2 | 1.13 Billion TWD | 0.89% |
| 2023 Q3 | 1.27 Billion TWD | 12.59% |
| 2022 Q4 | 1.16 Billion TWD | 12.28% |
| 2022 FY | 1.16 Billion TWD | 27.56% |
| 2022 Q2 | 1.03 Billion TWD | 3.29% |
| 2022 Q1 | 1 Billion TWD | 10.34% |
| 2022 Q3 | 1.03 Billion TWD | -0.33% |
| 2021 FY | 910.24 Million TWD | 6.93% |
| 2021 Q3 | 967.29 Million TWD | 10.73% |
| 2021 Q4 | 910.24 Million TWD | -5.9% |
| 2021 Q1 | 869.07 Million TWD | 2.1% |
| 2021 Q2 | 873.52 Million TWD | 0.51% |
| 2020 Q3 | 992.16 Million TWD | 14.93% |
| 2020 Q4 | 851.23 Million TWD | -14.2% |
| 2020 FY | 851.23 Million TWD | -0.23% |
| 2020 Q2 | 863.3 Million TWD | -0.23% |
| 2020 Q1 | 865.31 Million TWD | 1.42% |
| 2019 Q3 | 834.5 Million TWD | -8.06% |
| 2019 Q2 | 907.65 Million TWD | -3.04% |
| 2019 Q1 | 936.11 Million TWD | -7.16% |
| 2019 Q4 | 853.18 Million TWD | 2.24% |
| 2019 FY | 853.18 Million TWD | -15.38% |
| 2018 Q2 | 1.1 Billion TWD | -4.96% |
| 2018 Q4 | 1 Billion TWD | -3.45% |
| 2018 FY | 1 Billion TWD | -10.13% |
| 2018 Q1 | 1.16 Billion TWD | 4.05% |
| 2018 Q3 | 1.04 Billion TWD | -5.88% |
| 2017 Q3 | 1.12 Billion TWD | 5.33% |
| 2017 FY | 1.12 Billion TWD | 9.44% |
| 2017 Q4 | 1.12 Billion TWD | 0.05% |
| 2017 Q2 | 1.06 Billion TWD | 4.05% |
| 2017 Q1 | 1.02 Billion TWD | -0.19% |
| 2016 Q2 | 1.1 Billion TWD | -2.06% |
| 2016 Q1 | 1.12 Billion TWD | 1.3% |
| 2016 FY | 1.02 Billion TWD | -8.08% |
| 2016 Q4 | 1.02 Billion TWD | -10.43% |
| 2016 Q3 | 1.14 Billion TWD | 3.44% |
| 2015 FY | 1.11 Billion TWD | -9.19% |
| 2015 Q1 | 1.13 Billion TWD | -7.48% |
| 2015 Q4 | 1.11 Billion TWD | -6.48% |
| 2015 Q2 | 1.06 Billion TWD | -5.84% |
| 2015 Q3 | 1.19 Billion TWD | 11.47% |
| 2014 FY | 1.22 Billion TWD | -4.33% |
| 2014 Q2 | 1.1 Billion TWD | -6.04% |
| 2014 Q3 | 1.24 Billion TWD | 12.77% |
| 2014 Q4 | 1.22 Billion TWD | -1.63% |
| 2014 Q1 | 1.17 Billion TWD | -8.22% |
| 2013 Q3 | 1.34 Billion TWD | 6.47% |
| 2013 Q4 | 1.28 Billion TWD | -4.49% |
| 2013 FY | 1.28 Billion TWD | 9.97% |
| 2013 Q2 | 1.26 Billion TWD | -0.32% |
| 2013 Q1 | 1.26 Billion TWD | 8.5% |
| 2012 Q1 | 1.23 Billion TWD | -3.66% |
| 2012 FY | 1.16 Billion TWD | -8.61% |
| 2012 Q4 | 1.16 Billion TWD | -0.12% |
| 2012 Q3 | 1.16 Billion TWD | 0.52% |
| 2012 Q2 | 1.16 Billion TWD | -5.51% |
| 2011 Q3 | 2.5 Billion TWD | 8.9% |
| 2011 Q1 | 1.85 Billion TWD | 8.46% |
| 2011 Q2 | 2.29 Billion TWD | 23.96% |
| 2011 Q4 | 1.27 Billion TWD | -48.97% |
| 2011 FY | 1.27 Billion TWD | -25.28% |
| 2010 Q4 | 1.7 Billion TWD | 0.0% |
| 2010 FY | 1.7 Billion TWD | 15.65% |
| 2009 FY | 1.47 Billion TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Apex Medical Corp. | 420.28 Million TWD | -196.803% |
| OK Biotech Co., Ltd. | 394.04 Million TWD | -216.57% |
| Applied BioCode Corporation | 174.97 Million TWD | -612.923% |